OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Change in covid-19 risk over time following vaccination with CoronaVac: test negative case-control study
Matt D. T. Hitchings, Otávio T. Ranzani, Margaret L. Lind, et al.
BMJ (2022), pp. e070102-e070102
Open Access | Times Cited: 13
Matt D. T. Hitchings, Otávio T. Ranzani, Margaret L. Lind, et al.
BMJ (2022), pp. e070102-e070102
Open Access | Times Cited: 13
Showing 13 citing articles:
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
Otávio T. Ranzani, Matt D. T. Hitchings, Rosana Leite de Melo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 87
Otávio T. Ranzani, Matt D. T. Hitchings, Rosana Leite de Melo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 87
Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study
Lucas Chaves Netto, Karim Yaqub Ibrahim, Camila de Melo Picone, et al.
The Lancet HIV (2022) Vol. 9, Iss. 5, pp. e323-e331
Open Access | Times Cited: 48
Lucas Chaves Netto, Karim Yaqub Ibrahim, Camila de Melo Picone, et al.
The Lancet HIV (2022) Vol. 9, Iss. 5, pp. e323-e331
Open Access | Times Cited: 48
Current Challenges With the Use of Test-Negative Designs for Modeling COVID-19 Vaccination and Outcomes
Xu Shi, Kendrick Qijun Li, Bhramar Mukherjee
American Journal of Epidemiology (2022) Vol. 192, Iss. 3, pp. 328-333
Open Access | Times Cited: 23
Xu Shi, Kendrick Qijun Li, Bhramar Mukherjee
American Journal of Epidemiology (2022) Vol. 192, Iss. 3, pp. 328-333
Open Access | Times Cited: 23
Effectiveness of an Inactivated Covid-19 Vaccine with Homologous and Heterologous Boosters against Omicron in Brazil
Otávio T. Ranzani, Matt D. T. Hitchings, Rosana Leite de Melo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 21
Otávio T. Ranzani, Matt D. T. Hitchings, Rosana Leite de Melo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 21
Confronting Health Misinformation Surrounding COVID-19 Vaccines in the State of Florida
Michael J. Haller, Daniel A. Rubin, Matt D. T. Hitchings
Journal of General Internal Medicine (2024) Vol. 39, Iss. 8, pp. 1488-1491
Open Access | Times Cited: 2
Michael J. Haller, Daniel A. Rubin, Matt D. T. Hitchings
Journal of General Internal Medicine (2024) Vol. 39, Iss. 8, pp. 1488-1491
Open Access | Times Cited: 2
The effectiveness of COVID–19 vaccination against all–cause mortality in patients with type 2 diabetes mellitus: The observation during the initial period of the cancellation of the “Dynamic Zero Policy” in mainland China
Shijun Liu, Caixia Jiang, Yan Liu, et al.
Diabetes Research and Clinical Practice (2023) Vol. 200, pp. 110694-110694
Open Access | Times Cited: 6
Shijun Liu, Caixia Jiang, Yan Liu, et al.
Diabetes Research and Clinical Practice (2023) Vol. 200, pp. 110694-110694
Open Access | Times Cited: 6
Evaluation of COVID-19 vaccines in primary prevention against infections and reduction in severity of illness following the outbreak of SARS-CoV-2 omicron variant in Shanghai
Dawei Yang, Huifen Weng, Rui Wang, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 4
Dawei Yang, Huifen Weng, Rui Wang, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 4
Effectiveness of inactivated COVID-19 vaccines against SARS-CoV-2 infections among healthcare personnel in Pakistan: a test-negative case–control study
Unab I. Khan, Mahnoor Niaz, Iqbal Azam, et al.
BMJ Open (2023) Vol. 13, Iss. 6, pp. e071789-e071789
Open Access | Times Cited: 4
Unab I. Khan, Mahnoor Niaz, Iqbal Azam, et al.
BMJ Open (2023) Vol. 13, Iss. 6, pp. e071789-e071789
Open Access | Times Cited: 4
Neutralizing and Total/IgG Spike Antibody Responses Following Homologous CoronaVac vs. BNT162b2 Vaccination Up to 90 Days Post-Booster
Chin Shern Lau, John Thundyil, May Lin Helen Oh, et al.
Antibodies (2022) Vol. 11, Iss. 4, pp. 70-70
Open Access | Times Cited: 6
Chin Shern Lau, John Thundyil, May Lin Helen Oh, et al.
Antibodies (2022) Vol. 11, Iss. 4, pp. 70-70
Open Access | Times Cited: 6
Exploring the potential benefits of mucosal COVID-19 vaccines: opportunities and challenges
Júlio Croda
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 10, pp. 1099-1100
Open Access | Times Cited: 3
Júlio Croda
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 10, pp. 1099-1100
Open Access | Times Cited: 3
Humoral immune response in people living with HIV after administration of SARS-CoV-2 vaccine CoronaVac or BNT162b2 or CoronaVac/BNT162b2 booster sequence: A cross-sectional study
Marcelo Wolff, Paulo Charpentier, Andrea Canals, et al.
Vaccine (2023) Vol. 42, Iss. 3, pp. 671-676
Open Access | Times Cited: 3
Marcelo Wolff, Paulo Charpentier, Andrea Canals, et al.
Vaccine (2023) Vol. 42, Iss. 3, pp. 671-676
Open Access | Times Cited: 3
IMMUNOLOGICAL STORM AND MULTIPLE ORGAN DAMAGE BY COVID-19
A. Yaser Arafath, S. Aifa Fathima, Anushara Prabhakaran, et al.
Medicine in Omics (2024) Vol. 11, pp. 100034-100034
Open Access
A. Yaser Arafath, S. Aifa Fathima, Anushara Prabhakaran, et al.
Medicine in Omics (2024) Vol. 11, pp. 100034-100034
Open Access
Association between cumulative exposure periods of flupentixol or any antipsychotics and risk of lung cancer
Yi Chai, Rachel Yui Ki Chu, Yuqi Hu, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 1
Yi Chai, Rachel Yui Ki Chu, Yuqi Hu, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 1
